Real Option in Biotechnological Firms Valuation. An Empirical Analysis of European Firms



Título del documento: Real Option in Biotechnological Firms Valuation. An Empirical Analysis of European Firms
Revue: Journal of technology management & innovation
Base de datos: CLASE
Número de sistema: 000322926
ISSN: 0718-2724
Autores: 1
2
Instituciones: 1Universidad Europea de Madrid, Madrid. España
2Universidad Autónoma de Madrid, Madrid. España
Año:
Volumen: 1
Número: 2
Paginación: 27-52
País: Chile
Idioma: Inglés
Tipo de documento: Artículo
Enfoque: Analítico
Resumen en inglés Firms’ intangible assets are becoming more and more relevant in the different areas within the financial discipline. Its management, its quantification and its valuation nowadays constitute one of the main challenges which economy and business try to face. Through this paper we will evaluate some models based on the real options theory in order to estimate the intangible assets value of certain firms, specifically I+D biotechnological firms projects. With this aim, and after deep research on biotechnological industry, we will establish the parameters regarding one model which can be considered as a quantitative valuation method that we apply to a sample of biotechnological European companies. The results obtained through the empirical analysis are promising and they support the use of the real options theory to evaluate biotechnological firms
Disciplinas: Economía,
Administración y contaduría
Palabras clave: Empresas,
Economía industrial,
Industria,
Activos intangibles,
Investigación y desarrollo,
Biotecnología,
Opciones reales,
Europa
Texte intégral: Texto completo (Ver HTML)